Skip to main content

GALECTIN THERAPEUTICS INC insider trading

GALTNASDAQ
$3.90+0.14 (+3.72%)as of Oct 2, 2026

“Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.” — Peter Lynch

Insider Trading vs Stock Price

Insider Trading vs Stock Price data

Showing the 1Y range: Oct 2, 2025 to Oct 2, 2026. Price (-8.2%). 0 insider transactions plotted in this window as 0 markers; nearby trades of the same kind are grouped.

Transactions plotted on the price chart
DateCategoryPersonRoleActionAmountChange in holding
Open market purchase
Open market sell
Marker size reflects transaction size.

Net dollar flow · Buy / Sell balance

Premium
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Unlock quarterly net flow

Key players

  • RERichard E. UihleinDirector44.3646%of company
  • JLJoel LewisPresident and CEO0.7717%of company
  • KDKevin D. FreemanDirector0.1466%of company
  • KEKary EldredDirector0.0695%of company
  • ZRZordani Richard A. Jr.Director0.0437%of company
  • JWJack W. CallicuttChief Financial Officer0.0076%of company
  • HHHarold H. ShlevinDirector0.0064%of company
  • KJKhurram JamilChief Medical Officer0.00%of company
  • HBHenry BremDirector0.00%of company
  • JCJames C. Czirr10% OwnerNot reportedof company

AI Activity Analysis

Premium
Coming soonAI reads of insider activity will appear here for Premium accounts.

Insider activity

Fromto
CompanyInsider / roleActionΔOwnAvg priceAmount
GALTKary EldredDirectorOpen market purchase$810+0.4%$2.70$810Feb 6, 2026Feb 9, 2026
GALTJoel LewisPresident and CEOOpen market sell$135K-4.3%$3.58$135KJan 6, 2026Jan 6, 2026
GALTJack W. CallicuttChief Financial OfficerOpen market sell$74.7K-72.8%$3.67$74.7KJan 6, 2026Jan 6, 2026
GALTKhurram JamilChief Medical OfficerOpen market sell$78.3K-100.0%$3.65$78.3KJan 6, 2026Jan 6, 2026
GALTJoel LewisPresident and CEOOpen market sell$108K-3.1%$3.91$108KJan 5, 2026Jan 6, 2026
GALTJack W. CallicuttChief Financial OfficerOpen market sell$100K-47.9%$3.90$100KJan 5, 2026Jan 6, 2026
GALTKhurram JamilChief Medical OfficerOpen market sell$99.4K-54.3%$3.90$99.4KJan 5, 2026Jan 6, 2026
GALTKary EldredDirectorOpen market purchase$2.61K+1.0%$3.73$2.61KDec 23, 2025Dec 23, 2025
GALTKary EldredDirectorOpen market purchase$2.61K+1.0%$3.73$2.61KDec 23, 2025Dec 23, 2025
GALTJames C. Czirr10% OwnerOpen market sell$204K-0.5%$6.66$204KDec 16, 2025Dec 18, 2025
GALT10X Capital Management, LLC10% OwnerOpen market sell$757K-2.3%$5.73$757KDec 3, 2025Dec 8, 2025
GALT10X Capital Management, LLC10% OwnerOpen market sell$164K-0.5%$5.47$164KDec 2, 2025Dec 8, 2025
GALT10X Capital Management, LLC10% OwnerOpen market sell$210K-0.7%$5.25$210KNov 11, 2025Nov 12, 2025
GALTJack W. CallicuttChief Financial OfficerOpen market sell$7.51K-7.6%$6.01$7.51KNov 3, 2025Nov 5, 2025
GALT10X Capital Management, LLC10% OwnerOpen market sell$148K-0.5%$4.94$148KOct 22, 2025Oct 24, 2025
GALT10X Capital Management, LLC10% OwnerOpen market sell$98.6K-0.3%$4.93$98.6KOct 22, 2025Oct 24, 2025
End of history · 16 transactions

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.